<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-049435</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Post-polio syndrome: a review of its clinical characteristics and treatment</dc:title>
<dc:description xml:lang="en">Introduction. Post-polio syndrome (PPS) is recognised as a clinical syndrome that causes the late, progressivefunctional impairment suffered by survivors of an acute episode of poliomyelitis. The importance of PPS is acknowledged byincreasingly wider sectors of the population and health care sectors; nevertheless, few reports have been published about itsepidemiology or its clinical characteristics and treatment. Aim. To review the current scientific evidence available on theclinical manifestations, risk factors, prevalence, diagnosis and recommendations for treatment of PPS. Development. Weconducted a review of the medical literature in the MEDLINE database. The search was restricted to studies conducted inhumans that had been published as complete works in English and/or Spanish up to December 2004. Conclusions. PPS isrecognised as being a specific neurological syndrome that appears several decades after the acute episode of polio; itexacerbates the motor sequelae already present in these patients and reduces their functional capacity to a point where it affectstheir activities of daily living. Its causation has still not been clearly identified and it constitutes a process that is difficult todiagnose and manage. In addition, no specific treatment has been developed for this condition to date. Nevertheless, thepsychological and functional impact it has on its victims and the possibility of bringing about a significant improvement in thesymptoms call for a greater effort by professionals to identify the clinical needs imposed by the syndrome and to break downsome of the health care barriers that currently exist</dc:description>
<dc:creator>Amate, J. M</dc:creator>
<dc:creator>Bouza, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. El síndrome pospolio (SPP) se reconocecomo un síndrome clínico causante del deterioro funcional tardío yprogresivo que sufren los supervivientes de un episodio de poliomielitisaguda. La importancia del SPP se reconoce por sectores cadavez más amplios de la población y las esferas sanitarias; sin embargo,tanto su epidemiología como sus características clínicas y sutratamiento están escasamente documentados. Objetivo. Revisar laevidencia científica actualmente disponible sobre las manifestacionesclínicas, factores de riesgo, prevalencia, diagnóstico y recomendacionesde tratamiento del SPP. Desarrollo. Revisión de la literaturamédica en la base de datos MEDLINE. La búsqueda se ha restringidoa estudios en humanos publicados de forma completa en inglésy/o castellano hasta diciembre de 2004. Conclusiones. El SPP se reconocecomo un síndrome neurológico específico que aparece variasdécadas después del episodio agudo de polio, agrava las secuelasmotoras ya presentes en dichos pacientes y reduce su capacidadfuncional hasta afectar las actividades de la vida diaria. Su etiologíaaún no ha sido claramente identificada y constituye un procesode difícil diagnóstico y manejo para el cual aún no existe un tratamientoespecífico. Sin embargo, el impacto psicológico y funcionalque supone en los afectados y la posibilidad de una notable mejoríasintomática exigen un esfuerzo de identificación por parte de losprofesionales de manera que se reconozcan las necesidades clínicasque dicho síndrome impone y se reduzcan las barreras asistencialesexistentes en la actualidad</dc:description>
<dc:source>Rev Neurol;43(5): 295-301, sept. 2006. tab</dc:source>
<dc:identifier>ibc-049435</dc:identifier>
<dc:title xml:lang="es">Síndrome pospolio: revisión de sus características clínicas y tratamiento</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d29087^s22032</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d29087^s22016</dc:subject>
<dc:subject>^d29087^s22027</dc:subject>
<dc:subject>^d3103</dc:subject>
<dc:subject>^d29087^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d14955</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d32676^s22027</dc:subject>
<dc:subject>^d10333^s22027</dc:subject>
<dc:subject>^d28561</dc:subject>
<dc:subject>^d29087^s22053</dc:subject>
<dc:subject>^d4479^s22027</dc:subject>
<dc:subject>^d3883^s22027</dc:subject>
<dc:subject>^d5325^s22027</dc:subject>
<dc:subject>^d11483^s22012</dc:subject>
<dc:subject>^d13275</dc:subject>
<dc:subject>^d23977</dc:subject>
<dc:subject>^d27926</dc:subject>
<dc:type>article</dc:type>
<dc:date>200609</dc:date>
</metadata>
</record>
</ibecs-document>
